The Synergist
ActiveThe Synergist has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.16M and a net result of €345k. Equity is growing by ~34.4% per year across the filed fiscal years. Its solvency ranks better than 43% of 188 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
78
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability77▲+3
Solvency68▲+13
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €160k at 30 days acceptable
Liquidity ample (current ratio 7.01 against 7.78 in 2024; short-term debt: 13.6% and cash: 5% of total assets), but 57% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
43%
Return on assets
6.9%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-08-2026, 11 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
11 d late
2024
15 d early
2023
65 d late
2022
30 d late
2021
30 d late
2020
2 d early
2019
87 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
18-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€345k▲ 37.6%
2024 · €251k
2018: €45k
2019: €16k
2020: €130k
2021: €347k
2022: €347k
2023: €161k
2024: €251k
2018 → 2025
Working capital
€4.11M▼ 21.2%
2024 · €5.21M
2018: €1.09M
2019: €1.45M
2020: €1.95M
2021: €2.03M
2022: €3.34M
2023: €4.16M
2024: €5.21M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€838k-€1.18M▲ 41.4%€1.35M▲ 13.6%€1.85M▲ 37.7%€2.16M▲ 16.3%
Operating result€353k-€310k▼ 12.4%€115k▼ 62.8%€204k▲ 77.4%€309k▲ 51.0%
Net result€347k-€347k▲ 0.1%€161k▼ 53.7%€251k▲ 56.2%€345k▲ 37.6%
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 51% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €5.01M
Fixed assets
€215k▼ 17.2%
Current assets
€4.79M▼ 19.9%
Equity and liabilities €5.01M
Equity
€2.16M▲ 16.3%
Debt
€2.85M▼ 35.0%
The debt ratio falls from 70.3% to 57.0%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€353k▲
2024 · €206k
Cash flow
€390k▲
2024 · €253k
Solvency
43.0%▲
2024 · 29.7%
Current ratio
7.01▼
2024 · 7.78
Quick ratio
7.01▼
2024 · 7.78
Debt / equity
1.32▼
2024 · 2.37
ROE
16.0%▲
2024 · 13.5%
ROA
6.9%▲
2024 · 4.0%
Interest coverage
11.97▼
2024 · 20.79
Debt
€2.85M▼
2024 · €4.39M
Debt ≤ 1 year
€683k▼
2024 · €768k
Income taxes
€18k▼
2024 · €18k
Staff costs
€538k▲
2024 · €439k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€6.24M€5.01M▼
Fixed assets21/28€260k€215k▼
Intangible fixed assets21-€213k
Tangible fixed assets22/27€260k€2k▼
Furniture and vehicles24€4k€2k▼
Assets under construction and advance payments27€256k€0▼
Current assets29/58€5.98M€4.79M▼
Amounts receivable within one year40/41€2.22M€1.92M▼
Trade receivables40€1.00M€727k▼
Other amounts receivable41€1.22M€1.20M▼
Current investments50/53€1.77M€2.60M▲
Cash at bank and in hand54/58€1.97M€251k▼
Deferred charges and accrued income490/1€16k€22k▲
Equity and liabilities
Total equity and liabilities10/49€6.24M€5.01M▼
Equity10/15€1.85M€2.16M▲
Reserves13€516k€516k=
Profit (loss) carried forward14€1.08M€1.43M▲
Investment grants15€256k€213k▼
Amounts payable17/49€4.39M€2.85M▼
Amounts payable within one year42/48€768k€683k▼
Trade debts44€736k€606k▼
Suppliers440/4€736k€606k▼
Taxes, remuneration and social security45€32k€77k▲
Taxes450/3€6k€10k▲
Remuneration and social security454/9€26k€67k▲
Accrued charges and deferred income492/3€3.62M€2.17M▼
Income statement
Code20242025
Remuneration, social security and pensions62€439k€538k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€45k▲
Other operating charges640/8€0-
Non-recurring operating charges66A€143€0▼
Gross operating margin9900€645k€891k▲
Operating profit (loss)9901€204k€309k▲
Financial income75/76B€75k€84k▲
Recurring financial income75€75k€84k▲
Financial charges65/66B€10k€30k▲
Recurring financial charges65€10k€30k▲
Profit (loss) for the period before taxes9903€269k€363k▲
Income taxes67/77€18k€18k▼
Profit (loss) for the period9904€251k€345k▲
Profit (loss) for the period to be appropriated9905€251k€345k▲
Appropriation of the result
Profit (loss) to be appropriated9906€1.08M€1.43M▲
Profit (loss) brought forward from the previous period14P€830k€1.08M▲
To contributions691€0-
Social balance
Average headcount (FTE)90872.03.4▲
The notes to these accounts (19 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
11-08
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 11 days late
2025
31-12
Financial
Equity above €2MEq €2.16M ▲16.3%
8 profitable years in a row build equity to €2.16M.
16-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
04-10
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 65 days late
2023
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 30 days late
2022
31-12
Financial
Highest result since 2018net €347k ▲0.1%
Net result €347k, the highest in the series.
31-12
Financial
Equity above €1MEq €1.18M ▲41.4%
5 profitable years in a row build equity to €1.18M.
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 30 days late
2021
31-12
Financial
Equity above €500kEq €838k ▲70.6%
4 profitable years in a row build equity to €838k.
29-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
26-10
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 87 days late
2019
31-12
Financial
Weakest financial yearnet €16k ▼65.2%
Net result drops to €16k, the lowest in the series; recovery starts the following year.
09-10
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 70 days late
2018
09-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
30-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 9 acts read
About the unread acts
We know of 9 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
9 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2014
Ground area
5,672 m²
Building footprint
3,878 m²
Volume, LiDAR
86,391 m³
Parcel 21807G0131/00T000, Brussels · tallest building 45.8 m, ±8 floors. Linked by address, not a title deed.
1 establishment unit
the synergist
since 20142.225.759.624
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21807G0131/00T000 | Brussels | 5,672 m² | 1 · 3,878 m² | 45.8 m · 8 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
European research
8 projects · 2,055,683 EUR EU contributionProgrammes
HORIZON
h2020
Projects
REpresentative Clinical Research - ADvancing Inclusivity in Europe
GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD
Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation
Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.
Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment
Show 3 more projects
Social media platform dedicated to rare diseases, using collective intelligence for the generation of awareness and advanced knowledge on this large group of diseases.
SYNergies for Cohorts in Health: integrating the ROle of all Stakeholders
Advancing Equity, Diversity and Inclusion in Clinical Trials
Recognitions · licences · registrations
Legal Entity Identifier
699400E3PQZPEE2D5I09
Similar companies · same sector, comparable size
HEARTKINETICS
BE 0728.461.387
Charleroi · Eq €1.78M
THERAtRAME
BE 0786.448.581
Liège · Eq €1.75M
Dr. Hellebuyck Hans
BE 0864.410.649
Middelkerke · Eq €1.74M
Dr.DHOORE
BE 0877.795.560
Sint-Lievens-Houtem · Eq €2.69M
DOKTERS OLIVIER en DEVOS
BE 0829.094.830
Gistel · Eq €1.64M
Of 423 companies in sector 72200 we hold annual accounts for 145. 75 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formNon-profit association
Founded15-07-2013
Fiscal year end31-12
Activities, NACEBEL
70210Activities of head offices; management consultancy activities
72200Scientific research and development
73300Public relations and communication consultancy
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 12 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.